KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) EBT Margin (2016 - 2025)

Repligen (RGEN) has disclosed EBT Margin for 16 consecutive years, with 9.66% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin fell 2061.0% to 9.66% in Q4 2025 year-over-year; TTM through Dec 2025 was 8.45%, a 137.0% decrease, with the full-year FY2025 number at 8.45%, down 137.0% from a year prior.
  • EBT Margin was 9.66% for Q4 2025 at Repligen, up from 9.06% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 30.27% in Q4 2024 to a low of 6.8% in Q4 2022.
  • A 5-year average of 13.69% and a median of 10.6% in 2023 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: tumbled -2549bps in 2022, then soared 2915bps in 2024.
  • Repligen's EBT Margin stood at 18.68% in 2021, then crashed by -136bps to 6.8% in 2022, then surged by 116bps to 1.12% in 2023, then skyrocketed by 2604bps to 30.27% in 2024, then tumbled by -68bps to 9.66% in 2025.
  • Per Business Quant, the three most recent readings for RGEN's EBT Margin are 9.66% (Q4 2025), 9.06% (Q3 2025), and 9.99% (Q2 2025).